 | • レポートコード：MRC2-11QY12758 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は結核治療薬のグローバル市場について調査・分析したレポートです。種類別（活動性結核、潜在性結核）市場規模、用途別（病院、診療所、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別結核治療薬の競争状況、市場シェア ・世界の結核治療薬市場：種類別市場規模 2015年-2020年（活動性結核、潜在性結核） ・世界の結核治療薬市場：種類別市場規模予測 2021年-2026年（活動性結核、潜在性結核） ・世界の結核治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、薬局） ・世界の結核治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、薬局） ・北米の結核治療薬市場分析：米国、カナダ ・ヨーロッパの結核治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの結核治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の結核治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの結核治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Lupin、Novartis、Macleods Pharmaceuticals、Otsuka Pharmaceutical、Pfizer、Eli Lilly、Labatec Pharma、Mylan、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes, or talks.
Market Analysis and Insights: Global Tuberculosis Treatment Drugs Market
The global Tuberculosis Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tuberculosis Treatment Drugs Scope and Market Size
Tuberculosis Treatment Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Tuberculosis Treatment Drugs market is segmented into
Active TB
Latent TB
Segment by Application, the Tuberculosis Treatment Drugs market is segmented into
Hospital
Clinic
Durgstore
Regional and Country-level Analysis
The Tuberculosis Treatment Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tuberculosis Treatment Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tuberculosis Treatment Drugs Market Share Analysis
Tuberculosis Treatment Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tuberculosis Treatment Drugs business, the date to enter into the Tuberculosis Treatment Drugs market, Tuberculosis Treatment Drugs product introduction, recent developments, etc.
The major vendors covered:
Johnson & Johnson
Lupin
Novartis
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Pfizer
Eli Lilly
Labatec Pharma
Mylan
Sanofi
1 Study Coverage
1.1 Tuberculosis Treatment Drugs Product Introduction
1.2 Market Segments
1.3 Key Tuberculosis Treatment Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Treatment Drugs Market Size Growth Rate by Type
1.4.2 Active TB
1.4.3 Latent TB
1.5 Market by Application
1.5.1 Global Tuberculosis Treatment Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Durgstore
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Treatment Drugs Market Size, Estimates and Forecasts
2.1.1 Global Tuberculosis Treatment Drugs Revenue 2015-2026
2.1.2 Global Tuberculosis Treatment Drugs Sales 2015-2026
2.2 Global Tuberculosis Treatment Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tuberculosis Treatment Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tuberculosis Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tuberculosis Treatment Drugs Competitor Landscape by Players
3.1 Tuberculosis Treatment Drugs Sales by Manufacturers
3.1.1 Tuberculosis Treatment Drugs Sales by Manufacturers (2015-2020)
3.1.2 Tuberculosis Treatment Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Tuberculosis Treatment Drugs Revenue by Manufacturers
3.2.1 Tuberculosis Treatment Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Tuberculosis Treatment Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tuberculosis Treatment Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tuberculosis Treatment Drugs Revenue in 2019
3.2.5 Global Tuberculosis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tuberculosis Treatment Drugs Price by Manufacturers
3.4 Tuberculosis Treatment Drugs Manufacturing Base Distribution, Product Types
3.4.1 Tuberculosis Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tuberculosis Treatment Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Tuberculosis Treatment Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Treatment Drugs Market Size by Type (2015-2020)
4.1.1 Global Tuberculosis Treatment Drugs Sales by Type (2015-2020)
4.1.2 Global Tuberculosis Treatment Drugs Revenue by Type (2015-2020)
4.1.3 Tuberculosis Treatment Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tuberculosis Treatment Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Tuberculosis Treatment Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Tuberculosis Treatment Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Tuberculosis Treatment Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tuberculosis Treatment Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Treatment Drugs Market Size by Application (2015-2020)
5.1.1 Global Tuberculosis Treatment Drugs Sales by Application (2015-2020)
5.1.2 Global Tuberculosis Treatment Drugs Revenue by Application (2015-2020)
5.1.3 Tuberculosis Treatment Drugs Price by Application (2015-2020)
5.2 Tuberculosis Treatment Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Tuberculosis Treatment Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Tuberculosis Treatment Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Tuberculosis Treatment Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tuberculosis Treatment Drugs by Country
6.1.1 North America Tuberculosis Treatment Drugs Sales by Country
6.1.2 North America Tuberculosis Treatment Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tuberculosis Treatment Drugs Market Facts & Figures by Type
6.3 North America Tuberculosis Treatment Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Tuberculosis Treatment Drugs by Country
7.1.1 Europe Tuberculosis Treatment Drugs Sales by Country
7.1.2 Europe Tuberculosis Treatment Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tuberculosis Treatment Drugs Market Facts & Figures by Type
7.3 Europe Tuberculosis Treatment Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tuberculosis Treatment Drugs by Region
8.1.1 Asia Pacific Tuberculosis Treatment Drugs Sales by Region
8.1.2 Asia Pacific Tuberculosis Treatment Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tuberculosis Treatment Drugs Market Facts & Figures by Type
8.3 Asia Pacific Tuberculosis Treatment Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tuberculosis Treatment Drugs by Country
9.1.1 Latin America Tuberculosis Treatment Drugs Sales by Country
9.1.2 Latin America Tuberculosis Treatment Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tuberculosis Treatment Drugs Market Facts & Figures by Type
9.3 Central & South America Tuberculosis Treatment Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Treatment Drugs by Country
10.1.1 Middle East and Africa Tuberculosis Treatment Drugs Sales by Country
10.1.2 Middle East and Africa Tuberculosis Treatment Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tuberculosis Treatment Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Tuberculosis Treatment Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Tuberculosis Treatment Drugs Products Offered
11.1.5 Johnson & Johnson Related Developments
11.2 Lupin
11.2.1 Lupin Corporation Information
11.2.2 Lupin Description and Business Overview
11.2.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Lupin Tuberculosis Treatment Drugs Products Offered
11.2.5 Lupin Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Tuberculosis Treatment Drugs Products Offered
11.3.5 Novartis Related Developments
11.4 Macleods Pharmaceuticals
11.4.1 Macleods Pharmaceuticals Corporation Information
11.4.2 Macleods Pharmaceuticals Description and Business Overview
11.4.3 Macleods Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Macleods Pharmaceuticals Tuberculosis Treatment Drugs Products Offered
11.4.5 Macleods Pharmaceuticals Related Developments
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Corporation Information
11.5.2 Otsuka Pharmaceutical Description and Business Overview
11.5.3 Otsuka Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Otsuka Pharmaceutical Tuberculosis Treatment Drugs Products Offered
11.5.5 Otsuka Pharmaceutical Related Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description and Business Overview
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Tuberculosis Treatment Drugs Products Offered
11.6.5 Pfizer Related Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Description and Business Overview
11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly Tuberculosis Treatment Drugs Products Offered
11.7.5 Eli Lilly Related Developments
11.8 Labatec Pharma
11.8.1 Labatec Pharma Corporation Information
11.8.2 Labatec Pharma Description and Business Overview
11.8.3 Labatec Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Labatec Pharma Tuberculosis Treatment Drugs Products Offered
11.8.5 Labatec Pharma Related Developments
11.9 Mylan
11.9.1 Mylan Corporation Information
11.9.2 Mylan Description and Business Overview
11.9.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Mylan Tuberculosis Treatment Drugs Products Offered
11.9.5 Mylan Related Developments
11.10 Sanofi
11.10.1 Sanofi Corporation Information
11.10.2 Sanofi Description and Business Overview
11.10.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sanofi Tuberculosis Treatment Drugs Products Offered
11.10.5 Sanofi Related Developments
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Tuberculosis Treatment Drugs Products Offered
11.1.5 Johnson & Johnson Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tuberculosis Treatment Drugs Market Estimates and Projections by Region
12.1.1 Global Tuberculosis Treatment Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Tuberculosis Treatment Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Tuberculosis Treatment Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Tuberculosis Treatment Drugs Sales Forecast (2021-2026)
12.2.2 North America: Tuberculosis Treatment Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Tuberculosis Treatment Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Tuberculosis Treatment Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Tuberculosis Treatment Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Tuberculosis Treatment Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Tuberculosis Treatment Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tuberculosis Treatment Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tuberculosis Treatment Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tuberculosis Treatment Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tuberculosis Treatment Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Tuberculosis Treatment Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Tuberculosis Treatment Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Tuberculosis Treatment Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Tuberculosis Treatment Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tuberculosis Treatment Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tuberculosis Treatment Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tuberculosis Treatment Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tuberculosis Treatment Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tuberculosis Treatment Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tuberculosis Treatment Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Tuberculosis Treatment Drugs Market Segments
Table 2. Ranking of Global Top Tuberculosis Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tuberculosis Treatment Drugs Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Active TB
Table 5. Major Manufacturers of Latent TB
Table 6. Global Tuberculosis Treatment Drugs Market Size Growth Rate by Application 2020-2026 (Kg)
Table 7. Global Tuberculosis Treatment Drugs Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 8. Global Tuberculosis Treatment Drugs Sales by Regions 2015-2020 (Kg)
Table 9. Global Tuberculosis Treatment Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Tuberculosis Treatment Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Tuberculosis Treatment Drugs Sales by Manufacturers (2015-2020) (Kg)
Table 12. Global Tuberculosis Treatment Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Tuberculosis Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Tuberculosis Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Treatment Drugs as of 2019)
Table 15. Tuberculosis Treatment Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Tuberculosis Treatment Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Tuberculosis Treatment Drugs Price (2015-2020) (USD/Kg)
Table 18. Tuberculosis Treatment Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Tuberculosis Treatment Drugs Product Type
Table 20. Date of International Manufacturers Enter into Tuberculosis Treatment Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Tuberculosis Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 23. Global Tuberculosis Treatment Drugs Sales Share by Type (2015-2020)
Table 24. Global Tuberculosis Treatment Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Tuberculosis Treatment Drugs Revenue Share by Type (2015-2020)
Table 26. Tuberculosis Treatment Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 27. Global Tuberculosis Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 28. Global Tuberculosis Treatment Drugs Sales Share by Application (2015-2020)
Table 29. North America Tuberculosis Treatment Drugs Sales by Country (2015-2020) (Kg)
Table 30. North America Tuberculosis Treatment Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Tuberculosis Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Tuberculosis Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Tuberculosis Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 34. North America Tuberculosis Treatment Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Tuberculosis Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 36. North America Tuberculosis Treatment Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Tuberculosis Treatment Drugs Sales by Country (2015-2020) (Kg)
Table 38. Europe Tuberculosis Treatment Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Tuberculosis Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Tuberculosis Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Tuberculosis Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 42. Europe Tuberculosis Treatment Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Tuberculosis Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 44. Europe Tuberculosis Treatment Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Tuberculosis Treatment Drugs Sales by Region (2015-2020) (Kg)
Table 46. Asia Pacific Tuberculosis Treatment Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Tuberculosis Treatment Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Tuberculosis Treatment Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Tuberculosis Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 50. Asia Pacific Tuberculosis Treatment Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Tuberculosis Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 52. Asia Pacific Tuberculosis Treatment Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Tuberculosis Treatment Drugs Sales by Country (2015-2020) (Kg)
Table 54. Latin America Tuberculosis Treatment Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Tuberculosis Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Tuberculosis Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Tuberculosis Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 58. Latin America Tuberculosis Treatment Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Tuberculosis Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 60. Latin America Tuberculosis Treatment Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Tuberculosis Treatment Drugs Sales by Country (2015-2020) (Kg)
Table 62. Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Tuberculosis Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Tuberculosis Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Tuberculosis Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 66. Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Tuberculosis Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 68. Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share by Application (2015-2020)
Table 69. Johnson & Johnson Corporation Information
Table 70. Johnson & Johnson Description and Major Businesses
Table 71. Johnson & Johnson Tuberculosis Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 72. Johnson & Johnson Product
Table 73. Johnson & Johnson Recent Development
Table 74. Lupin Corporation Information
Table 75. Lupin Description and Major Businesses
Table 76. Lupin Tuberculosis Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Lupin Product
Table 78. Lupin Recent Development
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Major Businesses
Table 81. Novartis Tuberculosis Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Novartis Product
Table 83. Novartis Recent Development
Table 84. Macleods Pharmaceuticals Corporation Information
Table 85. Macleods Pharmaceuticals Description and Major Businesses
Table 86. Macleods Pharmaceuticals Tuberculosis Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Macleods Pharmaceuticals Product
Table 88. Macleods Pharmaceuticals Recent Development
Table 89. Otsuka Pharmaceutical Corporation Information
Table 90. Otsuka Pharmaceutical Description and Major Businesses
Table 91. Otsuka Pharmaceutical Tuberculosis Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Otsuka Pharmaceutical Product
Table 93. Otsuka Pharmaceutical Recent Development
Table 94. Pfizer Corporation Information
Table 95. Pfizer Description and Major Businesses
Table 96. Pfizer Tuberculosis Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Pfizer Product
Table 98. Pfizer Recent Development
Table 99. Eli Lilly Corporation Information
Table 100. Eli Lilly Description and Major Businesses
Table 101. Eli Lilly Tuberculosis Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. Eli Lilly Product
Table 103. Eli Lilly Recent Development
Table 104. Labatec Pharma Corporation Information
Table 105. Labatec Pharma Description and Major Businesses
Table 106. Labatec Pharma Tuberculosis Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. Labatec Pharma Product
Table 108. Labatec Pharma Recent Development
Table 109. Mylan Corporation Information
Table 110. Mylan Description and Major Businesses
Table 111. Mylan Tuberculosis Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Mylan Product
Table 113. Mylan Recent Development
Table 114. Sanofi Corporation Information
Table 115. Sanofi Description and Major Businesses
Table 116. Sanofi Tuberculosis Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Sanofi Product
Table 118. Sanofi Recent Development
Table 119. Global Tuberculosis Treatment Drugs Sales Forecast by Regions (2021-2026) (Kg)
Table 120. Global Tuberculosis Treatment Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Tuberculosis Treatment Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Tuberculosis Treatment Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Tuberculosis Treatment Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 124. North America: Tuberculosis Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Tuberculosis Treatment Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 126. Europe: Tuberculosis Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Tuberculosis Treatment Drugs Sales Forecast by Region (2021-2026) (Kg)
Table 128. Asia Pacific: Tuberculosis Treatment Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Tuberculosis Treatment Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 130. Latin America: Tuberculosis Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Tuberculosis Treatment Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 132. Middle East and Africa: Tuberculosis Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Tuberculosis Treatment Drugs Players
Table 137. Tuberculosis Treatment Drugs Customers List
Table 138. Tuberculosis Treatment Drugs Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Treatment Drugs Product Picture
Figure 2. Global Tuberculosis Treatment Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Active TB Product Picture
Figure 4. Latent TB Product Picture
Figure 5. Global Tuberculosis Treatment Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Durgstore
Figure 9. Tuberculosis Treatment Drugs Report Years Considered
Figure 10. Global Tuberculosis Treatment Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Tuberculosis Treatment Drugs Sales 2015-2026 (Kg)
Figure 12. Global Tuberculosis Treatment Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Tuberculosis Treatment Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Tuberculosis Treatment Drugs Sales Market Share by Region in 2019
Figure 15. Global Tuberculosis Treatment Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Tuberculosis Treatment Drugs Revenue Market Share by Region in 2019
Figure 17. Global Tuberculosis Treatment Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Tuberculosis Treatment Drugs Revenue in 2019
Figure 19. Tuberculosis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Tuberculosis Treatment Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Tuberculosis Treatment Drugs Sales Market Share by Type in 2019
Figure 22. Global Tuberculosis Treatment Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Tuberculosis Treatment Drugs Revenue Market Share by Type in 2019
Figure 24. Global Tuberculosis Treatment Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Tuberculosis Treatment Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Tuberculosis Treatment Drugs Sales Market Share by Application in 2019
Figure 27. Global Tuberculosis Treatment Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Tuberculosis Treatment Drugs Revenue Market Share by Application in 2019
Figure 29. North America Tuberculosis Treatment Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 30. North America Tuberculosis Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Tuberculosis Treatment Drugs Sales Market Share by Country in 2019
Figure 32. North America Tuberculosis Treatment Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 34. U.S. Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 36. Canada Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Tuberculosis Treatment Drugs Market Share by Type in 2019
Figure 38. North America Tuberculosis Treatment Drugs Market Share by Application in 2019
Figure 39. Europe Tuberculosis Treatment Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 40. Europe Tuberculosis Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Tuberculosis Treatment Drugs Sales Market Share by Country in 2019
Figure 42. Europe Tuberculosis Treatment Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 44. Germany Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 46. France Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 48. U.K. Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 50. Italy Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 52. Russia Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Tuberculosis Treatment Drugs Market Share by Type in 2019
Figure 54. Europe Tuberculosis Treatment Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Tuberculosis Treatment Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 56. Asia Pacific Tuberculosis Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Tuberculosis Treatment Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Tuberculosis Treatment Drugs Revenue Market Share by Region in 2019
Figure 59. China Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 60. China Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 62. Japan Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 64. South Korea Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 66. India Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 68. Australia Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 70. Taiwan Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 72. Indonesia Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 74. Thailand Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 76. Malaysia Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 78. Philippines Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 80. Vietnam Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Tuberculosis Treatment Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Tuberculosis Treatment Drugs Market Share by Application in 2019
Figure 83. Latin America Tuberculosis Treatment Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 84. Latin America Tuberculosis Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Tuberculosis Treatment Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Tuberculosis Treatment Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 88. Mexico Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 90. Brazil Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 92. Argentina Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Tuberculosis Treatment Drugs Market Share by Type in 2019
Figure 94. Latin America Tuberculosis Treatment Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Tuberculosis Treatment Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 96. Middle East and Africa Tuberculosis Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Tuberculosis Treatment Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 100. Turkey Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 102. Saudi Arabia Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Tuberculosis Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 104. U.A.E Tuberculosis Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Tuberculosis Treatment Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Tuberculosis Treatment Drugs Market Share by Application in 2019
Figure 107. North America Tuberculosis Treatment Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 108. North America Tuberculosis Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Tuberculosis Treatment Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 110. Europe Tuberculosis Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Tuberculosis Treatment Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 112. Asia Pacific Tuberculosis Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Tuberculosis Treatment Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 114. Latin America Tuberculosis Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Tuberculosis Treatment Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 116. Middle East and Africa Tuberculosis Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
結核治療の世界市場（～2026年） Market Analysis and Insights: Global Tuberculosis Treatment Market The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tuberculosis Treatment Scope and Market Size Tuberculosis Treatment m…- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- 結核診断・治療の世界市場（～2026年） An infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. The rising screening rate in the high burden regions, faster clinical decisions, and affordability of d…
- 抗結核治療薬の世界市場（～2026年） Tuberculosis (TB) is an infectious disease, which is caused by Mycobacterium tuberculosis. These bacteria generally infect human lungs. However, it can infect other body parts/organs as well. Three major types of tuberculosis are found: latent, active, and drug-resistant tuberculosis. Symptoms are n…
- 結核（TB）診断の世界市場（～2026年） Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of lat…